Key Insights

Highlights

Treatment Research

2 treatments under study, led by 2 Mg Prucalopride Plus 2 L Polyethylene Glycol Regimen

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • 2 Mg Prucalopride Plus 2 L Polyethylene Glycol Regimen1
  • 2 Mg Placebo Plus 2 L Polyethylene Glycol Regimen1

Active Sponsors

  • Shandong University1
  • Linyi People's Hospital1
  • Tai'an People's Hospital1
  • Binzhou People's Hospital1

Top Investigators

Activity Timeline